Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER),
progesterone receptors (PR), and human epidermal growth factor receptors (HER2). The …

Heterogeneity of triple-negative breast cancer is well known at clinical, histopathological,
and molecular levels. Genomic instability and greater mutation rates, which may result in the …

Simple Summary Cobalt (Co) is an essential element with ubiquitous dietary exposure and
possible incremental exposure due to dietary supplements, occupations, and medical …

The beginning of the end or the end of the beginning? After two years mastered by
coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The …

Triple-negative breast cancer (TNBC) is the most aggressive and hard-to-treat form of breast
cancer. TNBC has a higher propensity for earlier relapse and an increased risk of metastasis …

The cytochrome P450 (CYP) enzyme family is the major enzyme system catalyzing the
phase I metabolism of xenobiotics, including pharmaceuticals and toxic compounds in the …

Curcumin, a hydrophobic polyphenol extracted from the rhizome of Curcuma longa, is now
considered a candidate drug for the treatment of neurological diseases, including …

Triple negative breast cancer (TNBC) is a highly aggressive subtype with a poor prognosis
due to its high rates of proliferation and metastasis. Recently, hydrogen sulfide (H 2 S) has …

We have developed an N-heterocyclic carbene (NHC) and base-mediated [3+ 3] annulation
reaction of unsaturated carboxylic esters and sulfonium salts for rapid and direct access to …

This study investigated the fabrication of gallic acid‐loaded chitosan nanoparticles (Gal‐Chi‐
NPs) that enhanced the DNA damage and apoptotic features by inhibiting FEN‐1 …